| Manipulation of host-cell pathways by bacterial pathogens AP Bhavsar, JA Guttman, BB Finlay Nature 449 (7164), 827-834, 2007 | 617 | 2007 |
| Exome sequencing and the management of neurometabolic disorders M Tarailo-Graovac, C Shyr, CJ Ross, GA Horvath, R Salvarinova, XC Ye, ... New England Journal of Medicine 374 (23), 2246-2255, 2016 | 317 | 2016 |
| A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer F Aminkeng, AP Bhavsar, H Visscher, SR Rassekh, Y Li, JW Lee, ... Nature genetics 47 (9), 1079-1084, 2015 | 259 | 2015 |
| Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity F Aminkeng, CJD Ross, SR Rassekh, S Hwang, MJ Rieder, AP Bhavsar, ... British journal of clinical pharmacology 82 (3), 683-695, 2016 | 219 | 2016 |
| Development and Characterization of a Xylose-Dependent System for Expression of Cloned Genes inBacillus subtilis: Conditional Complementation of a Teichoic … AP Bhavsar, X Zhao, ED Brown Applied and environmental microbiology 67 (1), 403-410, 2001 | 191 | 2001 |
| Teichoic Acid Is an Essential Polymer in Bacillus subtilis That Is Functionally Distinct from Teichuronic Acid AP Bhavsar, LK Erdman, JW Schertzer, ED Brown Journal of bacteriology 186 (23), 7865-7873, 2004 | 149 | 2004 |
| Cell wall assembly in Bacillus subtilis: how spirals and spaces challenge paradigms AP Bhavsar, ED Brown Molecular microbiology 60 (5), 1077-1090, 2006 | 134 | 2006 |
| Peptidomimetic inhibitors of the human cytomegalovirus protease W Ogilvie, M Bailey, MA Poupart, Abraham, A Bhavsar, P Bonneau, ... Journal of medicinal chemistry 40 (25), 4113-4135, 1997 | 133 | 1997 |
| Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood CD van Karnebeek, WS Sly, CJ Ross, R Salvarinova, J Yaplito-Lee, ... The American Journal of Human Genetics 94 (3), 453-461, 2014 | 111 | 2014 |
| The Salmonella Type III Effector SspH2 Specifically Exploits the NLR Co-chaperone Activity of SGT1 to Subvert Immunity AP Bhavsar, NF Brown, J Stoepel, M Wiermer, DDO Martin, KJ Hsu, ... PLoS pathogens 9 (7), e1003518, 2013 | 105 | 2013 |
| The emerging era of pharmacogenomics: current successes, future potential, and challenges JW Lee, F Aminkeng, AP Bhavsar, K Shaw, BC Carleton, MR Hayden, ... Clinical genetics 86 (1), 21-28, 2014 | 98 | 2014 |
| Probing teichoic acid genetics with bioactive molecules reveals new interactions among diverse processes in bacterial cell wall biogenesis MA D'Elia, KE Millar, AP Bhavsar, AM Tomljenovic, B Hutter, C Schaab, ... Chemistry & biology 16 (5), 548-556, 2009 | 83 | 2009 |
| Precise deletion of tagD and controlled depletion of its product, glycerol 3-phosphate cytidylyltransferase, leads to irregular morphology and lysis of Bacillus subtilis grown … AP Bhavsar, TJ Beveridge, ED Brown Journal of bacteriology 183 (22), 6688-6693, 2001 | 75 | 2001 |
| Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners SD Auweter, AP Bhavsar, CL de Hoog, Y Li, YA Chan, J van der Heijden, ... Journal of Biological Chemistry 286 (27), 24023-24035, 2011 | 72 | 2011 |
| Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ... Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019 | 68 | 2019 |
| The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300 SR Shames, AP Bhavsar, MA Croxen, RJ Law, SHC Mak, W Deng, Y Li, ... Cellular microbiology 13 (10), 1542-1557, 2011 | 66 | 2011 |
| The TagB protein in Bacillus subtilis 168 is an intracellular peripheral membrane protein that can incorporate glycerol phosphate onto a membrane-bound acceptor in vitro AP Bhavsar, R Truant, ED Brown Journal of Biological Chemistry 280 (44), 36691-36700, 2005 | 63 | 2005 |
| Clinical practice recommendations for the management and prevention of cisplatin-induced hearing loss using pharmacogenetic markers JW Lee, K Pussegoda, SR Rassekh, JG Monzon, G Liu, S Hwang, ... Therapeutic drug monitoring 38 (4), 423-431, 2016 | 60 | 2016 |
| Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer BI Drögemöller, JG Monzon, AP Bhavsar, AE Borrie, B Brooks, ... JAMA oncology 3 (11), 1558-1562, 2017 | 58 | 2017 |
| Global impact of Salmonella pathogenicity island 2-secreted effectors on the host phosphoproteome K Imami, AP Bhavsar, H Yu, NF Brown, LD Rogers, BB Finlay, LJ Foster Molecular & Cellular Proteomics 12 (6), 1632-1643, 2013 | 43 | 2013 |
